Recent Finacing
Recent Raise
Semma Therapeutics develops pluripotent stem cell–derived pancreatic beta cells paired with an implantable immune-protective delivery device to enable islet replacement therapies without lifelong immunosuppression.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors